The reduced expression of AQP5 in humans results in increased mucus production; genetic polymorphisms in AQP5 have been associated with declines in lung capacity and function in COPD patients [133,134,135]. The gene discussed is AQP5; the disease is chronic obstructive pulmonary disease.